EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische Studie

Effects of Insulin Dosage Adjustment on Hemodialysis Day for Blood Glucose Levels, Glycated Albumin, Interleukin‐6, and TNF‐α in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease

Hendra Zufry iD, Krishna Wardhana Sucipto, Agustia Sukri Ekadamayanti, Sarah Firdausa, Maulina Debbyousha

Seminars in Dialysis · 2025

DOI: 10.1111/sdi.70007 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Seminars in Dialysis, 2025. Verfasst von Hendra Zufry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism, and Diabetes - Thyroid Center, Department of Internal Medicine, School of Medicine, Universitas Syiah Kuala, B…. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Insulin. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies suggested adjusting insulin doses during hemodialysis to reduce intra‐ and post‐hemodialysis hypoglycemia. However, the impact of insulin adjustment on cardiovascular morbidity and mortality in diabetic patients with end‐stage renal disease (ESRD) remains unclear. Although reducing hypoglycemia is a well‐documented benefit of insulin dose modification in this population, the broader metabolic and inflammatory consequences—particularly those related to cardiovascular risk—are not well understood. This study aimed to investigate the effects of a 25% reduction in total daily insulin dose on hemodialysis days in T2DM patients with ESRD, focusing on daily blood glucose profiles, glycated albumin, IL‐6, and TNF‐α.

Methods

A multicenter study with clinical trials was designed in five hemodialysis centers. It was a 4‐week clinical trial involving 17 eligible type 2 diabetic patients with ESRD on insulin therapy and regular hemodialysis. Self‐monitoring blood glucose was performed seven times a day before, during, and 1 month after the intervention. Blood samples were collected before and after the intervention. The Wilcoxon test was used to assess differences in daily glucose profiles, glycated albumin, IL‐6, and TNF‐α before and after insulin dose adjustment.

Results

After 1 month of adjusting total daily insulin dose during hemodialysis, no statistically significant difference was observed in daily blood glucose, IL‐6, and TNF‐α levels. However, glycated albumin levels increased both before and after the insulin dosage modification.

Conclusions

Reducing the total daily insulin dose by 25% during hemodialysis day effectively reduces hypoglycemia incidence intra‐ and post‐hemodialysis in T2DM patients with ESRD without impacting pro‐inflammatory factors IL‐6 and TNF‐α, which are associated with increased cardiovascular morbidity and mortality risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseDiabetes Mellitus, Type 2Hypoglycemic AgentsInsulinInterleukin-6Kidney Failure, ChronicTumor Necrosis Factor-alphaAgedFemaleHumansMaleMiddle AgedDose-Response Relationship, DrugGlycated Serum AlbuminGlycation End Products, AdvancedRenal DialysisSerum Albumin

Stichwörter der Autor:innen

TNF‐αblood glucoseclinical trialglycated albuminhemodialysis dayinsulin dose adjustmentinterleukin‐6

Substanzen

Blood GlucoseGlycated Serum AlbuminGlycation End Products, AdvancedHypoglycemic AgentsInsulinInterleukin-6Serum AlbuminTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Division of Endocrinology, Metabolism, and Diabetes - Thyroid Center, Department of Internal Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Division of Endocrinology, Metabolism, and Diabetes - Thyroid Center, Department of Internal Medicine, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia.
  • Innovation and Research Center of Endocrinology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Department of Internal Medicine, School of Medicine, Universitas Malikussaleh/Cut Meutia General Hospital, Lhokseumawe, Aceh, Indonesia.

ORCID-Profile: Hendra Zufry

Zitieren

APA

Zufry, H., Sucipto, K. W., Ekadamayanti, A. S., Firdausa, S., & Debbyousha, M. (2025). Effects of Insulin Dosage Adjustment on Hemodialysis Day for Blood Glucose Levels, Glycated Albumin, Interleukin‐6, and TNF‐α in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease. Seminars in Dialysis. https://doi.org/10.1111/sdi.70007

Vancouver

Zufry H, Sucipto KW, Ekadamayanti AS, Firdausa S, Debbyousha M. Effects of Insulin Dosage Adjustment on Hemodialysis Day for Blood Glucose Levels, Glycated Albumin, Interleukin‐6, and TNF‐α in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease. Seminars in Dialysis. 2025. doi:10.1111/sdi.70007

BibTeX
@article{Zufry2025,
  author = {Zufry, Hendra and Sucipto, Krishna Wardhana and Ekadamayanti, Agustia Sukri and Firdausa, Sarah and Debbyousha, Maulina},
  title = {Effects of Insulin Dosage Adjustment on Hemodialysis Day for Blood Glucose Levels, Glycated Albumin, Interleukin‐6, and TNF‐α in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease},
  journal = {Seminars in Dialysis},
  year = {2025},
  doi = {10.1111/sdi.70007}
}
Kostenlos starten →